Skip to main content

Advertisement

Log in

Synergistic defects of UNC13D and AP3B1 leading to adult hemophagocytic lymphohistiocytosis

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

A 32-year-old man of non-consanguineous Chinese parentage, with high-grade fever, rash, joint pain, nausea, and vomiting, was diagnosed as adult-onset still’s disease at his initial admission. Although prednisone had been taken, the patient presented with recurrent high-grade fever, rash, splenomegaly, hypertriglyceridemia, cryptogenic hepatitis, apparently elevated levels of serum ferritin(>20,000 μg/L), which met the proposed HLH diagnostic criteria, 2009. Sequence analysis of genomic DNA from the patient’s peripheral blood demonstrated heterozygous for UNC13D mutation: c. 1232 G>A, and AP3B1 mutation: c. 1075 A>G, which were predicted to be pathogenic. Unfortunately, at the time, molecular confirmation results for HLH were obtained, and this patient had died from progressive HLH disease with multiple organ dysfunction syndrome caused by shock. FHL should be considered in the differential diagnosis of adults who present with adult-onset still’s disease-like symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the international registry. FHL study group of the histiocyte society. Leukemia. 1996;10:197–203.

    CAS  PubMed  Google Scholar 

  2. Zur SU, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482–92.

    Article  Google Scholar 

  3. Zur SU, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14:827–34.

    Article  Google Scholar 

  4. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461–73.

    Article  CAS  PubMed  Google Scholar 

  5. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957–9.

    Article  CAS  PubMed  Google Scholar 

  6. de Saint BG, Menasche G, Fischer A. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol. 2010;10:568–79.

    Article  Google Scholar 

  7. Filipovich AH. Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am. 2008;28:293–313.

    Article  PubMed  Google Scholar 

  8. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983;140:221–30.

    Article  CAS  PubMed  Google Scholar 

  9. Stark B, Hershko C, Rosen N, Cividalli G, Karsai H, Soffer D. Familial hemophagocytic lymphohistiocytosis (FHLH) in Israel. I. Description of 11 patients of Iranian–Iraqi origin and review of the literature. Cancer. 1984;54:2109–21.

    Article  CAS  PubMed  Google Scholar 

  10. Ishii E, Ohga S, Imashuku S, Kimura N, Ueda I, Morimoto A, et al. Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences. Crit Rev Oncol Hematol. 2005;53:209–23.

    Article  PubMed  Google Scholar 

  11. Beaty AD, Weller C, Levy B, Vogler C, Ferguson WS, Bicknese A, et al. A teenage boy with late onset hemophagocytic lymphohistiocytosis with predominant neurologic disease and perforin deficiency. Pediatr Blood Cancer. 2008;50:1070–2.

    Article  PubMed  Google Scholar 

  12. Allen M, De Fusco C, Legrand F, Clementi R, Conter V, Danesino C, et al. Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica. 2001;86:499–503.

    CAS  PubMed  Google Scholar 

  13. Santoro A, Cannella S, Bossi G, Gallo F, Trizzino A, Pende D, et al. Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis. J Med Genet. 2006;43:953–60.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Marcenaro S, Gallo F, Martini S, Santoro A, Griffiths GM, Arico M, et al. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood. 2006;108:2316–23.

    Article  CAS  PubMed  Google Scholar 

  15. Sieni E, Cetica V, Santoro A, Beutel K, Mastrodicasa E, Meeths M, et al. Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3. J Med Genet. 2011;48:343–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Shotelersuk V, Dell’Angelica EC, Hartnell L, Bonifacino JS, Gahl WA. A new variant of Hermansky–Pudlak syndrome due to mutations in a gene responsible for vesicle formation. Am J Med. 2000;108:423–7.

    Article  CAS  PubMed  Google Scholar 

  17. Fontana S, Parolini S, Vermi W, Booth S, Gallo F, Donini M, et al. Innate immunity defects in Hermansky–Pudlak type 2 syndrome. Blood. 2006;107:4857–64.

    Article  CAS  PubMed  Google Scholar 

  18. Enders A, Zieger B, Schwarz K, Yoshimi A, Speckmann C, Knoepfle EM, et al. Lethal hemophagocytic lymphohistiocytosis in Hermansky–Pudlak syndrome type II. Blood. 2006;108:81–7.

    Article  CAS  PubMed  Google Scholar 

  19. Clark R, Griffiths GM. Lytic granules, secretory lysosomes and disease. Curr Opin Immunol. 2003;15:516–21.

    Article  CAS  PubMed  Google Scholar 

  20. Wenham M, Grieve S, Cummins M, Jones ML, Booth S, Kilner R, et al. Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1. Haematologica. 2010;95:333–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Zhang K, Johnson JA, Biroschak J, Villanueva J, Lee SM, Bleesing JJ, et al. Familial haemophagocytic lymphohistiocytosis in patients who are heterozygous for the A91V perforin variation is often associated with other genetic defects. Int J Immunogenet. 2007;34:231–3.

    Article  CAS  PubMed  Google Scholar 

  22. Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, Meller J, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118:5794–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Zhang K, Chandrakasan S, Chapman H, Valencia CA, Husami A, Kissell D, et al. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood. 2014;124:1331–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894–900.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863–74.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.

    Article  PubMed  Google Scholar 

  27. Manno EC, Salfa I, Palma P, Bertaina A, Lombardi A, Moretta F, et al. Familial hemophagocytic lymphohistiocytosis type 3 diagnosed at school age: a case report. J Pediatr Hematol Oncol. 2014;36:e128–30.

    Article  PubMed  Google Scholar 

  28. 李硕, 王晶石, 王旖旎, 张嘉, 汤然, 王昭. 147例噬血细胞综合征病因及预后分析. 临床血液学杂志. 2014:559–63.

  29. Wong KF, Chan JK, Lo ES, Wong CS. A study of the possible etiologic association of Epstein–Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Hum Pathol. 1996;27:1239–42.

    Article  CAS  PubMed  Google Scholar 

  30. Wong KF, Chan JK. Reactive hemophagocytic syndrome—a clinicopathologic study of 40 patients in an oriental population. Am J Med. 1992;93:177–80.

    Article  CAS  PubMed  Google Scholar 

  31. Imashuku S. Clinical features and treatment strategies of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44:259–72.

    Article  PubMed  Google Scholar 

  32. Felix FH, Leal LK, Fontenele JB. Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis. Rheumatol Int. 2009;29:973–4.

    Article  PubMed  Google Scholar 

  33. Yoshizaki A, Kawakami A, Aramaki T, Ida H, Eguchi K. Preferential recovery by an intensive initial therapy from hemophagocytic syndrome complicated with adult onset Still’s disease presenting as agranulocytosis and hypercytokinemia. Clin Exp Rheumatol. 2008;26:383.

    CAS  PubMed  Google Scholar 

  34. Hot A, Toh ML, Coppere B, Perard L, Madoux MH, Mausservey C, et al. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients. Med (Baltim). 2010;89:37–46.

    Article  Google Scholar 

  35. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program. 2009:127–31.

  36. Chen Y, Wang Z, Cheng Y, Tang Y. Novel mutations in the UNC13D gene carried by a Chinese neonate with hemophagocytic lymphohistiocytosis. Yonsei Med J. 2013;54:1053–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Yoon HS, Kim HJ, Yoo KH, Sung KW, Koo HH, Kang HJ, et al. UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis. Haematologica. 2010;95:622–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Dell’Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal proteins in Hermansky–Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell. 1999;3:11–21.

    Article  PubMed  Google Scholar 

  39. Huizing M, Scher CD, Strovel E, Fitzpatrick DL, Hartnell LM, Anikster Y, et al. Nonsense mutations in ADTB3A cause complete deficiency of the beta 3A Subunit of Adaptor Complex-3 and severe Hermansky–Pudlak Syndrome Type 2. Pediatr Res. 2002;51:150–8.

    Article  CAS  PubMed  Google Scholar 

  40. Clark RH, Stinchcombe JC, Day A, Blott E, Booth S, Bossi G, et al. Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse. Nat Immunol. 2003;4:1111–20.

    Article  CAS  PubMed  Google Scholar 

  41. Enders A. Lethal hemophagocytic lymphohistiocytosis in Hermansky–Pudlak syndrome type II. Blood. 2006;108:81–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 81200380) and the “863” Program of China (No. 2014AA020532).

Conflict of interest

All authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liang Huang.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, L., Zhu, L., Huang, L. et al. Synergistic defects of UNC13D and AP3B1 leading to adult hemophagocytic lymphohistiocytosis. Int J Hematol 102, 488–492 (2015). https://doi.org/10.1007/s12185-015-1807-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-015-1807-z

Keywords

Navigation